NCT02112526 2024-12-20Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell LymphomaAcerta Pharma BVPhase 1 Completed21 enrolled 11 charts